Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our Level2View

ADTX
Aditxt, Inc. Common Stock
stock NASDAQ

At Close
May 16, 2025 3:59:30 PM EDT
1.66USD+3.106%(+0.05)68,649
0.00Bid   0.00Ask   0.00Spread
Pre-market
May 16, 2025 8:54:30 AM EDT
1.67USD+3.727%(+0.06)1,662
After-hours
May 16, 2025 4:23:30 PM EDT
1.65USD-0.602%(-0.01)600
OverviewPrice & VolumeSplitsHistoricalExchange VolumeDark Pool LevelsDark Pool PrintsExchangesShort VolumeShort Interest - DailyShort InterestBorrow Fee (CTB)Failure to Deliver (FTD)ShortsTrendsNewsNews
Jan 18, 2022
08:56AM EST  Aditxt, Inc. (ADTX), a biotech innovation company, announced on Tuesday that iy has submitted two Emergency Use Authorization (EUA) applications for AditxtScore for COVID-19. This lab-developed blood test provides a more comprehensive profile of the body's immune response to COVID-19.   RTTNews
08:40AM EST  Aditxt Submits Requests For Emergency Use Authorization To FDA For AditxtScore For COVID-19 Tests   RTTNews
08:34AM EST  Aditxt Reports Submission Of 2 Requests For Emergency Use Authorization To FDA For AditxtScore For COVId-19 Tests To Measure Quantity, Quality Of Antibodies Against COVID, Variants Including Omicron   Benzinga
08:30AM EST  Aditxt Submits Two Requests for Emergency Use Authorization to FDA for AditxtScore(tm) for COVID-19 Tests Which Measure the Quantity and Quality of Antibodies Against COVID-19 and its Variants Including Omicron   Business Wire
Jan 14, 2022
09:00AM EST  Aditxt, Inc. to Participate in Edison Group's Global Healthcare "Open House" Virtual Conference From January 25th-27th, 2022   Business Wire
Jan 12, 2022
09:00AM EST  Aditxt Provides Online Business Update Townhall Meeting with Amro Albanna, Co-Founder & CEO   Business Wire
Jan 4, 2022
09:57PM EST  ADITXT INVESTOR ALERT BY THE FORMER ATTORNEY GENERAL OF LOUISIANA: Kahn Swick &   PR Newswire
Dec 29, 2021
09:12AM EST  Aditxt To Extend Worldwide Licensing Agreement, Granting Exclusivity In All Fields Of Use   RTTNews
09:06AM EST  Aditxt Signs Amendment To Extend Worldwide Licensing Agreement, Granting Exclusivity In All Fields Of Use   Benzinga
Dec 28, 2021
09:33AM EST  Aditxt Inc. (ADTX) said it has signed a share exchange agreement to acquire AiPharma Global Holdings LLC, a wholly-owned subsidiary of AiPharma Group Ltd.   RTTNews
09:03AM EST  Aditxt Signs Share Exchange Agreement to Acquire AiPharma in Cash, Stock Deal   Benzinga
09:03AM EST  Aditxt Signs Agreement To Acquire AiPharma   RTTNews
09:00AM EST  Aditxt Signs Share Exchange Agreement to Acquire AiPharma   Business Wire
05:32AM EST  Aditx Shares Spike 36% Premarket; No News to Account for Move   Benzinga
Dec 13, 2021
08:48AM EST  Aditxt Signs Non-Binding LoI To Acquire Point-of-Care Diagnostic Technology Development Company   RTTNews
08:46AM EST  Aditxt, Inc. Signs Non-Binding Letter Of Intent To Acquire A Point-of-Care Diagnostic Technology Development Company; Says The Target 'holds an exclusive license in U.S. & Canada for at-home and in-office rapid antigen COVID-19 test'   Benzinga
08:44AM EST  Aditxt, Inc. Signs Non-Binding Letter of Intent to Acquire Point-of-Care Diagnostic Technology Development Company   Business Wire
Dec 6, 2021
05:56PM EST  Aditxt Announces Closing of $17.4 Million Firm Commitment Public Offering of Common Stock and Warrants   Business Wire
Dec 2, 2021
09:31AM EST  Aditxt Extends Timeline To Sign Definitive Agreement To Acquire AiPharma Global To December 16, 2021   RTTNews
09:20AM EST  Aditxt Extends the Timeline to Sign the Definitive Agreement to Acquire AiPharma Global to December 16, 2021   Business Wire
Dec 1, 2021
02:34PM EST  Mid-Afternoon Market Update: Dow Rises Over 100 Points; CTI BioPharma Shares Plummet   Benzinga
12:45PM EST  Mid-Day Market Update: Build-A-Bear Jumps After Q3 Results; BeyondSpring Shares Slide   Benzinga
09:40AM EST  Aditxt Announces Pricing Of $17.4 Mln Public Offering Of Common Stock And Warrants Led By Leading Healthcare Investor   RTTNews
09:37AM EST  Aditxt Announces Pricing of $17.4M Firm Commitment Public Offering Of Common Stock   Benzinga
09:36AM EST  Aditxt Announces Pricing of $17.4 Million Firm Commitment Public Offering of Common Stock and Warrants Led by Leading Healthcare Investor   Business Wire
08:41AM EST  The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment; Regulatory Setbacks For CTI Biopharma, BioXcel; Favorable Ruling For Viatris In Tecfidera Patent Case   Benzinga
08:36AM EST  The Daily Biotech Pulse: Adcom Backs Merck's Oral COVID-19 Treatment, Regulatory Setbacks For CTI Biopharma, Favorable Ruling For BioXcel, Viatris In Tecfidera Patent Case   Benzinga
Nov 30, 2021
07:14PM EST  Aditxt Announces Proposed Public Offering of Common Stock and Warrants   Business Wire
Nov 22, 2021
09:00AM EST  The Largest Law Enforcement Agency in the State of Kansas, Johnson County Sherriff's Office, to Become First in the Nation to Deploy AditxtScore(tm) for Immune Scoring for its Employees and First Responders   Business Wire
Nov 12, 2021
12:00PM EST  Aditxt Webinar at 2pm ET to Explore PRESECO Results   Business Wire
08:53AM EST  Aditxt Consortium Partner Appili Therapeutics' Phase 3 PRESECO Trial Did Not Achieve Statistical Significance On The Primary Endpoint Of Time To Sustained Clinical Recovery   Benzinga
08:45AM EST  Aditxt Provides an Update Regarding its Target Acquisition AiPharma Global Holdings LLC   Business Wire
Nov 3, 2021
09:21AM EDT  Aditxt Partners With CLX Health To Offer AditxtScore For COVID-19 Immune Monitoring Service Through CLX's TrustAssure Platform   Benzinga
09:00AM EDT  Aditxt Partners With CLX Health to Offer AditxtScore(tm) for COVID-19 Immune Monitoring Service Through CLX's TrustAssure(tm) Platform   Business Wire
Oct 20, 2021
05:31PM EDT  Aditxt Announces Closing of $4.25 Million Public Offering   Business Wire
08:19AM EDT  Aditxt To Present At Dawson James Small Cap Growth Conference Thursday, Oct. 21, 2021 At 2:50 p.m. EDT   Benzinga
08:00AM EDT  Aditxt to Present at the Dawson James 6th Annual Small Cap Growth Conference in Florida on October 21, 2021   Business Wire
Oct 18, 2021
08:11AM EDT  Aditxt Prices Public Offering Of 2.83 Mln Shares At $1.50/shr   RTTNews
07:39AM EDT  Aditxt Prices 2,833,333 Share Common Stock Offering At $1.50/Share   Benzinga
07:38AM EDT  Aditxt Announces Pricing of $4.25 Million Public Offering   Business Wire
Oct 7, 2021
09:15AM EDT  Aditxt to Present at the LD Micro Main Event in Los Angeles on October 13, 2021   Business Wire
Oct 5, 2021
12:43PM EDT  Is The Rights Holder Of Antiviral Tablet Avigan / Reeqonus / Qifenda That Has Treated Over 1.5M COVID-19 Patients Since The Outbreak.   PR Newswire
09:14AM EDT  Aditxt Enters Transaction Agreement To Acquire AiPharma -   RTTNews
08:53AM EDT  Aditxt Signs Agreement To Acquire AiPharma; Stock Surges   RTTNews
08:47AM EDT  Aditxt Signs Transaction Agreement To Acquire Subsidiary Of AiPharma   Benzinga
08:45AM EDT  Aditxt Signs a Transaction Agreement to Acquire AiPharma, Rights Holder of Antiviral Tablet Avigan/Reeqonus/Qifenda Used in the Treatment of Over 1.5 Million COVID-19 Patients Outside the U.S. and Canada   Business Wire
08:01AM EDT  The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout   Benzinga
Sep 27, 2021
08:47AM EDT  Aditxt Appoints Corinne Pankovcin As President And Thomas Farley As CFO   RTTNews
08:47AM EDT  Aditxt Appoints Corinne Pankovcin As President And Thomas J. Farley As Chief Financial Officer As Company Prepares For Global Commercialization   Benzinga
Sep 21, 2021
08:20AM EDT  The Daily Biotech Pulse: Aprea Jumps On ESMO Presentation, Verrica Sinks On Regulatory Setback, Aerie CEO Quits, J&J Touts Positive COVID-19 Booster Shot Data   Benzinga
Sep 16, 2021
07:48AM EDT  The Daily Biotech Pulse: Leap, Phio, Silverback Among Early Movers On Oncology Conference Presentations, Aerie Slumps On Mixed Data, Axsome Commences Phase 3 Sleep Disorder Study   Benzinga
Sep 15, 2021
07:38AM EDT  The Daily Biotech Pulse: Lilly, Regeneron Ink COVID-19 Drug Deal With US, Regulatory Setback For Calliditas, Theravance To Cut 75% Jobs, 4 IPOs   Benzinga
Sep 9, 2021
08:28AM EDT  Aditxt Announces Partnership With SphereDX   RTTNews
08:28AM EDT  Aditxt, SphereDX Launch AditxtScore For COVID-19 In Kentucky, Ohio And Indiana To 'Address Individual Immune Status Uncertainty and Help Evaluate Cadence for Booster Shots'   Benzinga
08:26AM EDT  Aditxt, Inc. and SphereDX Launch AditxtScore(tm) for COVID-19 in Kentucky, Ohio and Indiana to Address Individual Immune Status Uncertainty and Help Evaluate Cadence for Booster Shots   Business Wire
Sep 7, 2021
09:15AM EDT  Aditxt Announces Closing of $11 Million Registered Direct Offering, and Funding of Bridge Loan Satisfying a Key Term of its Letter of Intent for Planned Acquisition of Commercial Stage Pharma Company with Anti-Viral COVID-19 Therapy   Business Wire
Aug 26, 2021
02:48PM EDT  Mid-Afternoon Market Update: Pure Storage Rises Following Strong Q2 Results; SelectQuote Shares Plunge   Benzinga
12:13PM EDT  Mid-Day Market Update: Dow Tumbles Over 100 Points; Ascendis Pharma Shares Spike Higher   Benzinga
10:19AM EDT  Mid-Morning Market Update: Markets Mixed; Dollar General Profit Beats Views   Benzinga
09:23AM EDT  Aditxt Says Certain Institutional Investors To Purchase 4.58 Mln Shares At Purchase Price Of $2.40/shr   RTTNews
09:15AM EDT  Aditxt Prices ~4.58M Share Offering At $2.40/Share   Benzinga
09:15AM EDT  Aditxt Announces Pricing of $11.0 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules   Business Wire
Aug 25, 2021
09:20AM EDT  Aditxt Signs LoI For Exclusive Rights To Negotiate Acquisition Of A Biopharmaceutical Company   RTTNews
09:16AM EDT  Aditxt Signs Letter Of Intent For Exclusive Rights To Negotiate Acquisition Of Biopharmaceutical Company Commercializing And Distributing Antiviral Oral Therapy For COVID-19   Benzinga
09:16AM EDT  Aditxt, Inc. Signs Letter of Intent for Exclusive Rights to Negotiate the Acquisition of a Biopharmaceutical Company Commercializing and Distributing Antiviral Oral Therapy for COVID-19   Business Wire
Aug 19, 2021
11:26AM EDT  From BZ Reopening Stocks Summit: Aditxt CEO Says Co Sends Data To Both The Individual And Clinician; Says Co's Digital Core 'Could' Be Included In A Digital Wallet, Says Its Up To Consumers   Benzinga
11:25AM EDT  From BZ Reopening Stocks Summit: Aditxt CEO Says Co Plans To Transfer From Pre-Clinical To Clinical By H2 In 2022   Benzinga
11:24AM EDT  From BZ Reopening Stocks Summit: Aditxt CEO Says 'We Are Not A Single-Molecule Company'   Benzinga
11:23AM EDT  From BZ Reopening Stocks Summit: Aditxt CEO Highlights Pre-Clinical Trials   Benzinga
11:20AM EDT  From BZ Reopening Stocks Summit: Aditxt CEO Says Co's Platform Works Beyond COVID-19   Benzinga
11:19AM EDT  From BZ Reopening Stocks Summit: Aditxt CEO Highlights Opening Of High-Capacity CLIA-Validated Facility   Benzinga
11:13AM EDT  From BZ Reopening Stocks Summit: Aditxt CEO Says 'We Must Take An Individual Approach To This Pandemic'   Benzinga
11:12AM EDT  From BZ Reopening Stocks Summit: Aditxt CEO Says We Need To Start Looking At 'Individual Immune Status' To Get Economy To Reopening Status   Benzinga
11:10AM EDT  From BZ Reopening Stocks Summit: Aditxt CEO Amro Albanna Begins Interviewing   Benzinga
Aug 11, 2021
08:03AM EDT  Aditxt, Inc. And Great Lakes Medical Laboratory Highlights Launch Of AditxtScore Immune Response Monitoring Tool In Michigan   Benzinga
08:00AM EDT  Aditxt, Inc. and Great Lakes Medical Laboratory Launch AditxtScore for COVID-19 in State of Michigan as a Personalized Approach to Addressing COVID-19 Pandemic   Business Wire
Aug 4, 2021
09:01AM EDT  Aditxt Earlier Announced Its Psoriasis Clinical Program Will Now Be Slated For 2022 Instead Of Dec. 2021   Benzinga
08:00AM EDT  Aditxt Provides Update on AditxtReprogramming's(tm) Apoptotic DNA Immunotherapy Therapeutic Platform   Business Wire
Jul 12, 2021
08:40AM EDT  Aditxt's COVID-19 Test To Include Specific Antibodies To Detect Individual Immune Response; Shares Rise   Benzinga
08:23AM EDT  Aditxt Inc. (ADTX) said that it has launched high-sensitivity neutralizing antibody test to detect individual immune response to COVID-19.   RTTNews
08:07AM EDT  Aditxt Launches High-Sensitivity Neutralizing Antibody Test to Detect Individual Immune Response to COVID-19   Benzinga
08:06AM EDT  Aditxt Launches Neutralizing Antibody Test To Detect Individual Immune Response To COVID-19; Stock Surges   RTTNews
08:00AM EDT  Aditxt Launches High-Sensitivity Neutralizing Antibody Test to Detect Individual Immune Response to COVID-19   Business Wire
Jul 7, 2021
08:00AM EDT  Aditxt Opens its First High-Capacity Immune Monitoring Center in Richmond, VA   Business Wire
Jul 2, 2021
04:31PM EDT  Aditx Therapeutics S-3 Shows Registration For $100M Mixed Securities Shelf Offering   Benzinga
Jun 18, 2021
08:06AM EDT  Aditx Therapeutics Appoints Lauren Chung To Board As An Independent Director   RTTNews
08:00AM EDT  Aditxt Announces the Appointment of Dr. Lauren Chung to its Board of Directors   Business Wire
Jun 15, 2021
08:15AM EDT  Aditx Technologies Reports Will Join Russell Microcap Index, Effective Jun. 28   Benzinga
08:02AM EDT  Aditxt Set to Join Russell Microcap(r) Index   PR Newswire
May 6, 2021
09:21AM EDT  Aditxt Signs Channel Partner Agreement With Meridian HSN To Make AditxtScore   RTTNews
08:42AM EDT  Aditxt Signs Channel Partner Agreement with Meridian HSN to Make AditxtScore for COVID-19 Available to its Network of Healthcare Provider Partners   Benzinga
08:03AM EDT  AditxtScore(tm) for COVID-19 Available to its Network of Healthcare Provider Partners   PR Newswire
May 3, 2021
02:16PM EDT  Aditx Therapeutics' Aditxt Outlines Plans To Build High-Capacity AditxtScore Center In Richmond, Virginia In H2'21   Benzinga
02:15PM EDT  Aditxt to Establish State-of-the-Art Immune Monitoring Center in Richmond, VA   PR Newswire
Apr 13, 2021
08:48AM EDT  Aditx Therapeutics Says Sunny Uberoi Has Joined As Its Chief Communications Officer   RTTNews
08:31AM EDT  Aditxt Therapeutics Names Sunny Uberoi as its first Chief Communications Officer   PR Newswire
Apr 6, 2021
08:46AM EDT  Aditx Therapeutics Reports HealthBar Will Be Offering AditxtScore For COVID-19 Throughout State Of Michigan   Benzinga
08:31AM EDT  COVID-19 Immunity Status Monitoring to Complement its Concierge and Drive-Thru Testing Services   PR Newswire
Apr 1, 2021
08:31AM EDT  AditxtScore(tm) for COVID-19 Immunity Status Monitoring through its Mobile Testing Centers   PR Newswire
07:41AM EDT  Medivolve To Offer AditxtScore Through Its Mobile Testing Centers   Benzinga
07:30AM EDT  Medivolve Inc. (Medivolve) (NEO:MEDV; OTC:COPRF; FRA:4NC) today announced that its wholly owned subsidiary, Collection Sites, LLC will offer AditxtScore for COVID-19 through its mobile testing centres. Aditx Therapeutics (Nasdaq: ADTX), is a biotech innovation company focused on improving the health of the immune system.   GlobeNewswire Inc
Mar 25, 2021
02:45PM EDT  Highlights From Day 1 Of Benzinga's Biotech Small Cap Conference   Benzinga
Mar 24, 2021
08:59AM EDT  Aditx Therapeutics Stock Is Trading Higher On Initiating Human Trials With Psoriasis Candidate By 2021   Benzinga
08:38AM EDT  Aditxt To Initiate First-In-Human Clinical Trials With Its Therapeutics Programs In Psoriasis By Year-End   RTTNews
08:31AM EDT  Aditxt to Initiate First-In-Human Clinical Trials with its Therapeutics   PR Newswire
Mar 23, 2021
07:12PM EDT  Benzinga's Biotech Small Cap Conference Schedule For Wednesday, Mar. 24, 2021   Benzinga
Mar 4, 2021
08:30AM EST  via NewMediaWire -- Aditx Therapeutics, Inc. (Aditxt) (the Company) (Nasdaq: ADTX), a biotech innovation company focused on improving the health of the immune system, today announced that Eazy Testing Inc. will be offering AditxtScore for COVID-19 throughout its California locations.   GlobeNewswire Inc
Jan 29, 2021
09:25AM EST  Dr. Tyan Will Lead and Advance Organ Transplantation Therapeutic Program   GlobeNewswire Inc
Jan 26, 2021
08:55AM EST  Aditxt Says Secures $5M Financing To Scale AditxtScore Operational Capacity   Benzinga
08:54AM EST  Balance Sheet Further Strengthened by Receipt of Additional $3.3 Million from Exercise of Existing Warrants   GlobeNewswire Inc
Jan 21, 2021
02:46PM EST  Mid-Day Market Update: Nasdaq Rises Over 50 Points; Dyne Therapeutics Shares Plummet   Benzinga
02:46PM EST  Mid-Afternoon Market Update: Dow Rises 50 Points; Vinco Ventures Shares Spike Higher   Benzinga
12:07PM EST  Mid-Day Market Update: Nasdaq Rises Over 50 Points; Dyne Therapeutics Shares Plummet   Benzinga
10:11AM EST  Mid-Morning Market Update: Markets Mixed; Union Pacific Profit Beats Views   Benzinga
08:08AM EST  Aditx Therapeutics Announces AditxtScore Immune Monitoring Service Will Be Operational On February 1st   Benzinga
08:00AM EST  AditxtScore Immune Monitoring Service Will be   GlobeNewswire Inc
Dec 14, 2020
08:07AM EST  Aditxt Signs Distribution Agreement With Todos Medical Ltd. For Adixtxt Score For COVID-19 Immune Monitoring Service   Benzinga
08:00AM EST  Aditxt Signs Distribution Agreement with Todos Medical Ltd. For   GlobeNewswire Inc
Dec 8, 2020
08:00AM EST  Aditxt to Present at the 13th Annual LD Micro Main Event Conference   GlobeNewswire Inc
Nov 30, 2020
08:30AM EST  To Indicate Interest in a Personal AditxtScore for COVID-19, Visit AditxtScore.com   GlobeNewswire Inc
Nov 20, 2020
08:00AM EST  Voorhies hasExtensive Business and Industry Experience in Diagnostics & Monitoring   GlobeNewswire Inc
Nov 19, 2020
12:04PM EST  Why Aditxt's Stock Is Trading Higher Today   Benzinga
08:37AM EST  Aditxt Secures CLIA Certification For AditxtScore Laboratory Operations In Richmond, VA, And Plans To Launch AditxtScore For COVID-19 As A Lab Developed Test   Benzinga
08:30AM EST  Upcoming Vaccines Increase the Need for Ongoing Monitoring of Presence and Durability of Immunity   GlobeNewswire Inc
Nov 13, 2020
08:15AM EST  ADiTx Therapeutics Q3 EPS $(0.37) Down From $(0.28) YoY   Benzinga
08:00AM EST  via NewMediaWire -- Aditx Therapeutics, Inc. (Aditxt) (the Company) (Nasdaq: ADTX), a life sciences company developing biotechnologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming, today provided a business update in conjunction with the filing of its Form 10-Q with the Securities and Exchange Commission.   GlobeNewswire Inc
Oct 2, 2020
04:09PM EDT  Aditxt Announces Its First AditxtEngage Event To Continue Its Series Of Investor Opportunities To Engage With The Company   Benzinga
04:05PM EDT  First AditxtEngageEvent with Amro Albanna, CEO, to be held onTuesday, October 6that 4:30pm ET   GlobeNewswire Inc
Oct 1, 2020
08:01AM EDT  Dr. Runge brings 35 years experience as an Emergency Medicine Physician, Federal Government Executive and Public Policy Strategist   GlobeNewswire Inc
Sep 10, 2020
04:30PM EDT  Aditx Therapeutics to Present at H.C. Wainwright 22nd Annual   GlobeNewswire Inc
09:43AM EDT  Aditx Therapeutics Announces Closing of Upsized $9.6 Million   GlobeNewswire Inc
08:54AM EDT  Physician, Media Personality Dr. Drew Pinsky Joins Aditx Therapeutics As Senior Advisor To AditxtScore For Scoring The Immune System   Benzinga
08:52AM EDT  Will Serve as Advisor and Brand Ambassador to Overall Platform and Individual Applications   GlobeNewswire Inc
Sep 3, 2020
09:14AM EDT  Aditx Therapeutics Signs Collaboration Agreement With Salveo Diagnostics   RTTNews
09:00AM EDT  Aditxt Signs Collaboration Agreement with Salveo Diagnostics to   GlobeNewswire Inc
Sep 2, 2020
02:30PM EDT  Mid-Afternoon Market Update: Dow Rises 300 Points; Vera Bradley Shares Jump On Upbeat Earnings   Benzinga
12:52PM EDT  Why ADiTx Stock Is Trading Lower Today   Benzinga
10:26AM EDT  Mid-Morning Market Update: Markets Open Higher; Macy's Beats Q2 Expectations   Benzinga
08:32AM EDT  Aditx Therapeutics Announces Pricing Of $9.6M Follow-On Public Offering Of 2.4M Units At $4/Unit   Benzinga
08:31AM EDT  Aditx Therapeutics Prices 2.4M Unit Public Offering At $4/Unit   Benzinga
08:30AM EDT  Aditx Therapeutics Announces Pricing of $9.6 Million Follow-On   GlobeNewswire Inc
Sep 1, 2020
10:22AM EDT  Mid-Morning Market Update: Markets Mostly Higher; Zoom Video Beats Q2 Estimates   Benzinga
Aug 25, 2020
08:00AM EDT  Mr. Kiaie has Extensive Experience in Medical Device Product Development   GlobeNewswire Inc
Aug 24, 2020
09:10AM EDT  Life sciences company Aditx Therapeutics, Inc. (ADTX) announced Monday that it has submitted an Emergency Use Authorization (EUA) application with the U.S. Food and Drug Administration (FDA) for AditxtScore for COVID-19 to be used in detecting antibodies against SARS-CoV-2 antigens.   RTTNews
08:32AM EDT  Aditxt Submits Emergency Use Authorization Application for AditxtScore Test for COVID-19   Benzinga
08:30AM EDT  Aditxt Submits Emergency Use Authorization (EUA) Application for   GlobeNewswire Inc
Aug 14, 2020
08:00AM EDT  30 Year Industry Veteran with FDA and EMA Experience will Assume Newly Created Executive Role   GlobeNewswire Inc
Aug 6, 2020
02:37PM EDT  Mid-Afternoon Market Update: Dow Jumps Over 100 Points; Denali Therapeutics Shares Spike Higher   Benzinga
12:02PM EDT  Mid-Day Market Update: OraSure Technologies Drops Following Downbeat Q2 Results; American Virtual Cloud Technologies Shares Gain   Benzinga
10:13AM EDT  Mid-Morning Market Update: Markets Edge Higher; Bristol-Myers Squibb Earnings Top Estimates   Benzinga
09:34AM EDT  Aditxt Earlier Announced Introduction Of AditxtScore For COVID-19 And Announced Completion Of Validation Studies By Stanford Blood Center   Benzinga
Aug 3, 2020
08:00AM EDT  via NEWMEDIAWIRE Aditx Therapeutics, Inc. (Aditxt) (the Company) (Nasdaq: ADTX), a life sciences company developing technologies specifically focused on improving the health of the immune system through immune monitoring and reprogramming, today announced that it has appointed Jeff Ramson as Senior Advisor, Capital Markets and Communications.   GlobeNewswire Inc
Jul 24, 2020
08:00AM EDT  Ms. Anthony and Her Legal Team have Represented Private and Public Finance Transactions in excess of $1 Billion   GlobeNewswire Inc
Jul 22, 2020
08:00AM EDT  Presentation on Tuesday, July 28th at 11:00 AM ET   GlobeNewswire Inc
Jul 21, 2020
08:01AM EDT  Ms. Pankovcin has 30 Years of Public Company Financial Experience with World Class Organizations   GlobeNewswire Inc
Jul 14, 2020
05:11AM EDT  80 Biggest Movers From Yesterday   Benzinga


Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2025 ChartExchange LLC